Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-09-18 4:19 pm Sale | 13D | GALECTO INC GLTO | ORBIMED ADVISORS LLC | 749,557 2.8% | -400,137 (-34.80%) | View |
| 2023-09-14 4:21 pm Purchase | 13D | IKENA ONCOLOGY INC IKNA | ORBIMED ADVISORS LLC | 2,342,232 5.5% | 405,346 (+20.93%) | View |
| 2023-09-05 4:20 pm Sale | 13D | GALECTO INC GLTO | ORBIMED ADVISORS LLC | 1,149,694 4.2% | -457,885 (-28.48%) | View |
| 2023-08-23 4:56 pm Sale | 13D | PMV PHARMACEUTICALS INC PMVP | ORBIMED ADVISORS LLC | 6,563,077 13.5% | -26,253 (-0.40%) | View |
| 2023-08-17 4:30 pm Sale | 13D | GALECTO INC GLTO | ORBIMED ADVISORS LLC | 1,607,579 5.9% | -633,861 (-28.28%) | View |
| 2023-08-11 4:23 pm Purchase | 13D | GRACELL BIOTECHNOLOGIES INC SP GRCL | ORBIMED ADVISORS LLC | 7,641,531 8% | 57,955 (+0.76%) | View |
| 2023-08-03 4:59 pm Unchanged | 13D | XTANT MED HLDGS INC XTNT | ORBIMED ADVISORS LLC | 73,114,592 56.7% | 0 (Unchanged) | View |
| 2023-08-02 5:02 pm Sale | 13D | GALECTO INC GLTO | ORBIMED ADVISORS LLC | 2,241,440 8.3% | -214,200 (-8.72%) | View |
| 2023-07-24 4:33 pm Purchase | 13D | TURNSTONE BIOLOGICS CORP COM TSBX | ORBIMED ADVISORS LLC | 3,099,265 13.4% | 3,099,265 (New Position) | View |
| 2023-07-19 4:12 pm Purchase | 13D | THESEUS PHARMACEUTICALS INC CO THRX | ORBIMED ADVISORS LLC | 17,713,600 40.7% | 479,932 (+2.78%) | View |
| 2023-07-17 4:11 pm Sale | 13D | GALECTO INC GLTO | ORBIMED ADVISORS LLC | 2,455,640 9.6% | -241,014 (-8.94%) | View |
| 2023-06-29 4:36 pm Purchase | 13D | PASSAGE BIO INC PASG | ORBIMED ADVISORS LLC | 8,034,000 14.7% | 1,192,577 (+17.43%) | View |
| 2023-06-29 4:30 pm Purchase | 13D | ADICET BIO INC ACET | ORBIMED ADVISORS LLC | 6,647,598 15.5% | 6,647,598 (New Position) | View |
| 2023-06-21 4:53 pm Purchase | 13D | DISC MEDICINE INC IRON | ORBIMED ADVISORS LLC | 2,269,637 10.2% | 108,696 (+5.03%) | View |
| 2023-05-24 4:52 pm Sale | 13D | VECTIVBIO HLDG AG VECT | ORBIMED ADVISORS LLC | 5,156,561 7.7% | -1,557,000 (-23.19%) | View |
| 2023-05-24 4:47 pm Purchase | 13D | PRELUDE THERAPEUTICS INC PRLD | ORBIMED ADVISORS LLC | 15,716,642 28.6% | 869,565 (+5.86%) | View |
| 2023-05-17 4:46 pm Sale | 13D | SPRINGWORKS THERAPEUTICS INC C SWTX | ORBIMED ADVISORS LLC | 4,178,588 6.7% | -806,412 (-16.18%) | View |
| 2023-05-16 4:28 pm Unchanged | 13D | FUSION PHARMACEUTICALS INC FUSN | ORBIMED ADVISORS LLC | 2,930,670 4.6% | 0 (Unchanged) | View |
| 2023-05-16 4:25 pm Sale | 13D | VERONA PHARMA PLC SPONSORED AD VRNA | ORBIMED ADVISORS LLC | 3,777,778 4.8% | -482,913 (-11.33%) | View |
| 2023-05-08 5:01 pm Purchase | 13D | KINNATE BIOPHARMA INC KNTE | ORBIMED ADVISORS LLC | 7,559,729 16.2% | 1,460,932 (+23.95%) | View |